Research map: Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study

Back to the article

Papers in this map

  1. Atezolizumab, an Anti–Programmed Death-Ligand 1 Antibody, in Metastatic Renal Cell Carcinoma: Long-Term Safety, Clinical Activity, and Immune Correlates From a Phase Ia Study · David F. McDermott · 2016 · 563 citations · Cited by this paper
  2. Metabolites as agents and targets for cancer immunotherapy · Marcel P. Trefny · 2025 · 38 citations · Cites this paper
  3. HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · 2026 · Related
  4. Exploring vitamin D metabolism and function in cancer · Sang‐Min Jeon · 2018 · 555 citations · Cited by this paper
  5. Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours · Nina Fuller-Shavel · 2024 · 12 citations · Cites this paper
  6. Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · 2026 · Related
  7. Vitamin D and the Thyroid: A Critical Review of the Current Evidence · Mirjana Babić Leko · 2023 · 73 citations · Cited by this paper
  8. Higher serum vitamin D concentration and supplementation were associated with improved survival outcomes and treatment response in cancer patients receiving immunotherapy: A systematic review and meta-analysis · Qian Yang · 2025 · 10 citations · Cites this paper
  9. Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · 2026 · Related
  10. Untitled · Cited by this paper
  11. The impact of concomitant medications on treatment outcomes in patients with cancer receiving immune checkpoint inhibitors · Samantha Stone · 2025 · 10 citations · Cites this paper
  12. Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · 2026 · Related
  13. Untitled · Cited by this paper
  14. Vitamin D and Immune Checkpoint Inhibitors in Lung Cancer: A Synergistic Approach to Enhancing Treatment Efficacy · Yu Zhang · 2025 · 9 citations · Cites this paper
  15. Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · 2026 · Related
  16. Untitled · Cited by this paper
  17. Vitamin D3 and cancer risk in healthy subjects: An umbrella review of systematic review and meta-analysis · Fausto Petrelli · 2024 · 7 citations · Cites this paper
  18. Untitled · Cited by this paper
  19. Microbial metabolites for cancer immunotherapy: Current evidence and future directions · Xinxin Wang · 2025 · 7 citations · Cites this paper
  20. Untitled · Cited by this paper
  21. Role of Nutrients Regulating Myeloid Derived Suppressor Cells in Cancer: A Scoping Review · Beatriz Pérez-Peláez · 2024 · 6 citations · Cites this paper
  22. Untitled · Cited by this paper
  23. Vitamin D, Gut Microbiota, and Cancer Immunotherapy—A Potentially Effective Crosstalk · Yizhen Yan · 2025 · 6 citations · Cites this paper
  24. Untitled · Cited by this paper
  25. Effect of body mass index and cholesterol‐rich apolipoprotein‐B ‐containing lipoproteins on clinical outcome in NSCLC patients treated with immune checkpoint inhibitors‐based therapy: A retrospective analysis · Zixin Hu · 2024 · 3 citations · Cites this paper
  26. Untitled · Cited by this paper
  27. Immunometabolism in cancer: a systemic perspective · Helena Moretti · 2025 · 3 citations · Cites this paper
  28. Untitled · Cited by this paper
  29. Non-pharmacological Supportive Care Interventions during Immunotherapy for People with Cancer: A Systematic Scoping Review and Future Directions · Morgan Jane Farley · 2025 · 2 citations · Cites this paper
  30. Untitled · Cited by this paper
  31. Therapeutic implications of vitamin D in leukemia: mechanistic and clinical perspectives · Elham Moasser · 2025 · 1 citation · Cites this paper
  32. Untitled · Cited by this paper
  33. Pre-treatment endocrine–nutritional signatures predict clinical benefit from PD-1/PD-L1 blockade in hematologic malignancies · Ningjing Huang · 2026 · 1 citation · Cites this paper
  34. Untitled · Cited by this paper
  35. Pretreatment serum vitamin D levels predict the therapeutic efficacy of atezolizumab plus bevacizumab therapy in advanced hepatocellular carcinoma: a multicenter analysis · Takanori Suzuki · 2026 · Cites this paper
  36. Untitled · Cited by this paper
  37. The immunomodulatory role of vitamins in tumor: Mechanisms and therapeutic implications · Linlu Wen · 2026 · Cites this paper
  38. Untitled · Cited by this paper
  39. Nutraceuticals and Diet Supplements May Influence Cancer Immunotherapy · Saeede Soleimanian · 2024 · Cites this paper

Source: OpenAlex (CC0)